UK pharmas call for debate on drug access

image

London: The pharmaceutical industry today called for a public debate on access to modern medicines, and how society determines the value of new treatments.

The Association of the British Pharmaceutical Industry (ABPI) is inviting NICE, patient groups, medical professionals, the NHS and leading healthcare charities to debate the issues amid continuing controversy on the availability and cost of innovative medicines to NHS patients.

“A frank, open and honest debate is clearly in the interests of patients,” said Chris Brinsmead, President of the Association of the British Pharmaceutical Industry (ABPI).

“We are calling for the patient groups, healthcare charities, doctors, Government, NICE and the NHS to join with the pharmaceutical industry to debate these crucial issues to hammer out a lasting solution. The time has come to discuss how we best resolve the issue, and where better than on a public platform?”

The pharmaceutical industry spends approximately £3.9billion a year in the UK researching and developing new medicines for patients. This investment has delivered over 90 per cent of the medicines available today and has led to new treatments for rheumatoid arthritis, cancer, heart disease and HIV to name but a few, Mr Brinsmead added.

He said: “The UK pharmaceutical industry – along with other healthcare professionals and NICE – is committed to developing innovative approaches to pricing, ensuring that patients receive the medicines that they need. Taking the recent example of the four kidney cancer medicines, all these medicines are widely available to patients throughout Europe – where the prices are higher than in the UK.”

Mr Brinsmead said: “We are looking forward to hearing NICE’s response and welcome their contribution to what will be one of the most important debates in the history of modern healthcare.”

Image – Boy and Medicine: courtesy of MedicImage

About Elixir

image

Avril O’Connor is the Editor of Elixir News and Elixir magazine. It has been developed from a passion which began in 2002 when there was a proliferation of web sites selling anti-ageing products and services….but few with an independent voice.

In April 2005 Elixir News was born. It is editorially independent enabling consumers to better make informed choices about their health and anti-ageing products and services.

We do not accept payment to write endorsements of products and services or for the inclusion of experts and services in our directories. This enables Elixir News to be a credible and independent news source, as well as including all the services and professional experts that we consider relevant to our readership. Nevertheless inclusion is not an endorsement by us and should it come to our attention that any business mentioned on our site is being conducted in an illegal or unethical manner we will remove it from our directories.

Visitors to our site should also bear in mind that many claims are made for anti-ageing products and services that are not necessarily substantiated by scientific evidence and should always take the expert advice of a qualified medical doctor.

It is the intention of Elixir News to fairly report and investigate the facts. If we consider that any claims for products/services are bogus or unsubstantiated we will say so. If you have had negative experiences with businesses in this sector please let us know and we will take up the challenge. We also report on our positive experiences with products and services. Advertising or sponsorship is clearly labelled as such.

We hope that you will find our web site useful in arming you with knowledge that can help you live a longer and happier life. But once again we do advise anyone with persistent health problems to consult a qualified medical practitioner/doctor. Anyone embarking on a intensive anti-ageing programme should, in particular, seek the advice of a qualified specialist about the supplements they plan to take and in what quantities, as they may conflict with drug therapy and certain medical conditions. The doctor may advise certain blood and other tests to determine your individual needs.

Please do let us know about your experiences and feedback on the information within this site. Email us at info@elixirnews.com